ESCMID eAcademy

This content is restricted to ESCMID Members and to non-members that have registered.
1.1 VIDEO LECTURE
Discussion Forum (0)
Code of conduct/disclaimer available in General Terms & Conditions
To access this forum, you need to be logged in and registered to this activity.
Two innovations by MSF : AntibioGo (2) - Concept, microbiological aspects, AMS consequences
Dre Nada Malou
Dre Nada Malou
ESCMID eAcademy. Malou N. 01/25/2023; 375417; Disclosure(s): NA
user
Dre Nada Malou
Discussion Forum (0)
Code of conduct/disclaimer available in General Terms & Conditions

About Us

The European Society of Clinical Microbiology and Infectious Diseases is a non-profit organization whose mission is to improve the diagnosis, treatment and prevention of infection-related diseases. This is achieved by promoting and supporting research, education, training, and good medical practice.
2025 ©
European Society of Clinical Microbiology and Infectious Diseases
USER TERMS AND CONDITIONS / PRIVACY POLICY
(Amended according to GDPR)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies